Microneedle Patches Market Size
The Global Microneedle Patches Market reached US$ 855.9 million in 2024 and is expected to reach US$ 1560.1 million by 2033, growing at a CAGR of 6.9% during the forecast period 2025-2033.
Microneedle patches are a type of transdermal patch that has been embedded with an array of tiny needles to deliver the drug solution. The primary purpose of microneedle patches is to facilitate the delivery of drugs or bioactive compounds through the skin in a minimally invasive and painless manner. Unlike traditional hypodermic needles, which penetrate deeper layers of the skin, microneedles usually penetrate only the outermost layer of the skin, known as the stratum corneum or epidermis. This outer layer of the skin is relatively insensitive to pain and does not contain blood vessels or nerve endings, minimizing discomfort during application.
The market demand for microneedle patches has been rapidly increasing, driven by factors such as advancements in healthcare technologies, patient preferences for less invasive treatment options and the growing need for more efficient drug delivery systems. There is a growing demand for microneedle patches in dermatology and cosmetic procedures, such as anti-aging treatments, acne therapy, and skin rejuvenation. These patches offer efficient transdermal drug delivery, promoting better absorption of active ingredients.
For instance, in June 2023, researchers from the University of Hong Kong (HKUMed) designed a new microneedle patch for the treatment of skin infections. The research study was headed by HKUMed’s Department of Orthopaedics and Traumatology, School of Clinical Medicine professor Kelvin Yeung Wai-Kwok. The microneedle’s design, developed with ultrasound-responsive zinc-based metal-organic framework (MOF) antibacterial nanoparticles, ensures delivery without any pain to treat the infection on skin tissue while simultaneously facilitating skin repair. It enables the transdermal delivery of antibacterial nanoparticles for treating the infection caused by propionibacterium acnes (P. acnes) bacteria at a minimally invasive approach.
Executive Summary
For more details on this report – Request for Sample
Market Dynamics: Drivers & Restraints
Increasing adoption of minimally invasive procedures
The rising adoption of minimally invasive procedures is significantly driving the growth of the microneedle patches market and is expected to drive the market over the forecast period. Traditional injections and needle-based drug delivery methods can cause discomfort and require skilled professionals. Microneedle patches offer a virtually painless alternative, which significantly improves patient compliance and satisfaction.
For instance, in February 2021, researchers from Tohoku University developed a biobattery-powered device capable of both delivering large molecule pharmaceuticals across the skin barrier and extracting interstitial fluid for diagnostic purposes. The researchers powered the array with a biobattery. The biobattery and porous microneedle array are secured to the skin with an adhesive patch smaller than a business card. The successful demonstration shown here using a built-in biobattery proves the future possibility of a totally organic electroosmosis flow-based skin patch that is safe and truly disposable.
Microneedle patches enable patients to self-administer drugs at home, reducing the need for hospital visits. This is especially important for chronic disease management, such as for diabetes or vaccines, where regular treatments are needed. In diabetes care, microneedles are being developed for insulin delivery, allowing for daily self-administration without the pain of traditional needles.
For instance, according to the study conducted by the National Institute of Health (NIH), In vivo study in diabetic pigs showed that microneedle patches carrying 2.0 IU/kg insulin lowered the glucose level by 40% at 2 h points post-administration. The author also showed that the patch system can be sterilized by steaming in the final products avoiding the costly aseptic operation in the production process which was a great advancement for scale-up manufacturing. These rising positive clinical trials boost the demand for microneedle patches.
Safety and efficacy concerns
Safety and efficacy concerns are significant challenges that are hampering the growth of the microneedle patches market. Despite their potential advantages, issues related to these concerns are slowing their widespread adoption. Although microneedle patches are designed to be minimally invasive, improper usage or poorly designed patches can lead to skin irritation, infection, or allergic reactions. Since the needles penetrate the outermost layer of skin, there is a risk of breaking the skin barrier, leading to potential infection.
For instance, a study published in Nature Biomedical Engineering highlighted that improper application of microneedle patches could cause local irritation or discomfort in some individuals. In particular, the risk of infection may arise when the patches are not manufactured or used correctly, limiting their broader adoption.
Regulatory hurdles related to the approval of microneedle patch products can delay market entry and slow down adoption. Regulatory bodies such as the FDA and EMA require extensive clinical trials to prove the safety and efficacy of microneedle-based products before they can be marketed. This regulatory process is lengthy and costly, hindering the swift adoption of microneedle patches.
Microneedle patches are still in the clinical trial phase for various drug delivery applications, and the approval process remains slow. For instance, Vaxxas, a company developing microneedle patches for vaccines, is working on regulatory approval, with a timeline that could extend for several more years. This delay in market approval restricts the growth potential of the technology.
Market Segment Analysis
The global microneedle patches market is segmented based on product type, application, end-user and region.
Application:
The cosmetics segment is expected to dominate the microneedle patches market share
Microneedle patches are highly effective in delivering active ingredients such as hyaluronic acid, peptides, and growth factors deep into the skin, making them ideal for anti-aging care, whitening, blemish care, anti-aging treatments and skin rejuvenation. Consumers are increasingly opting for non-invasive cosmetic procedures over more invasive treatments like botox or surgery due to lower costs and reduced recovery times.
For instance, in November 2022, CGBio unveiled a skin trouble care patch as the first of its microneedle pipeline. Microneedles or microneedle patches are made from a variety of materials ranging from silicon, titanium, stainless steel, and polymers to increase the diffusivity of drugs to the stratum corneum by creating micron-size pores in the skin. With the launch of its skin trouble care patch named "CGDew Dermaregen," GBio aims to release functional patches for anti-aging care, whitening and blemish care. Because CGBio's Dermaregen is absorbed directly into the dermal layer of the skin through microneedles, it delivers active ingredients to the skin more efficiently than conventional spreading cosmetics.
Market Geographical Share
North America is expected to hold a significant position in the microneedle patches market share
North America is a hub for research and development, with numerous biotech and medical device companies leading innovation in microneedle technology. R&D is accelerating the development of advanced microneedle systems, improving their safety, efficacy, and affordability. Startups and research organizations in the U.S. and Canada are constantly improving microneedle design, aiming to address concerns around skin irritation and optimize drug delivery, driving future growth in the region.
For instance, according to the study conducted by the American Chemical Society (ACS), based on the study results, the team prepared MnPS3 microneedle patches and treated androgenic alopecia-affected mouse models with them. Within 13 days, the animals regenerated thicker hair strands that more densely covered their previously bald backsides than mice treated with testosterone or minoxidil. The researchers say that their study both produced a nanozyme treatment for regenerating hair and indicated the potential for computer-based methods for use in the design of future nanozyme therapeutics.
North America, particularly the United States, has a highly developed healthcare system with access to cutting-edge medical technologies and a strong regulatory framework. The FDA's approval processes are among the most rigorous globally, encouraging the development of safe, high-quality microneedle patch products. This robust regulatory environment supports the growth of microneedle patches for medical applications, including drug delivery, vaccination, and cosmetic treatments.
Asia-Pacific is growing at the fastest pace in the microneedle patches market
The Asia-Pacific region is home to one of the largest and most rapidly growing skincare and cosmetic markets. With increasing disposable incomes, rising awareness of skincare, and cultural emphasis on beauty, demand for innovative and effective skincare treatments like microneedle patches is soaring.
Melanoma accounts for only approximately 1% of skin cancers and is not a common type of skin cancer. However, it is a skin cancer with the highest mortality rate due to poor prognosis. Furthermore, the incidence rates and primary sites differ according to race. According to GLOBOCAN 2020 data, the age-standardized incidence and mortality rates of malignant melanoma worldwide are 3.4 and 0.56 per 100,000 people, respectively.
In Asia, these rates are lower at 0.42 and 0.21, respectively, than those found globally. According to the Korean Statistical Information Service, the age-standardized incidence rate of malignant melanoma in Korea has steadily increased from 0.8 in 1999 to 1.2 in 2020. In India, the incidence of melanoma of the skin in the North region is 1.62 for males and 1.21 for females for every 1,00,000 people. The overall incidence of nonmelanoma skin cancer is the highest in the Northeast region, going as high as 5.14 for men and 3.98 for women for every 1,00,000 people.
Melanoma in China has unique characteristics, especially compared with those in euramerican white race. In european and american countries, nearly 90% of melanoma patients are cutaneous melanoma; while 60% of melanoma in China are acral melanoma, accompanied with a considerable proportion of mucosal melanoma. Mapping the mutation landscape of melanoma in China can provide an important basis for targeted therapy of melanoma patients.
In Japan, melanoma is classified as a “rare cancer,” but the precise melanoma incidence in Japan has not been well investigated. Analysis of the Hospital Based Cancer Registries in Japan revealed the crude annual incidence of melanoma to be 1.75 per 100,000 people. In Japan, the amount of ultraviolet (UV) B exposure has been increasing almost continuously, but the present results suggest that the contribution of UV to the occurrence of malignant melanoma is not large.
Asia-Pacific countries, especially China, South Korea, and India, are becoming key hubs for medical device manufacturing and technological innovation, which accelerates the availability and affordability of microneedle patch products. For instance, in 2024, a South Korean QuadMedicine company developed an innovative micro-needle patch (MAP), a painless, cost-effective, and environmentally friendly way to administer vaccines and drugs in place of solid injections. QuadMedicine had patented the form of micro-needle patches that are separable MAPs, where the tips of the needle themselves are active APIs. The company is currently investigating comparable vaccines and drugs, for instance, the messenger mRNA vaccines that can be used in the microneedle or patch platform.
Major Global Players
The major global players in the microneedle patches market include Nissha.Co., Ltd., Taiki Group, AcusMu Medtech Co., Ltd., DermaJect, Azah Personal Care Pvt Ltd, WRINKLES SCHMINKLES PTY LTD, ESK CARE P/L, Remescar, DEPOLOGY, Beautical and among others.
Market Scope
| Metrics | Details | |
| CAGR | 6.9% | |
| Market Size Available for Years | 2018-2033 | |
| Estimation Forecast Period | 2025-2033 | |
| Revenue Units | Value (US$ Mn) | |
| Segments Covered | Product Type | Dissolvable Microneedle Patches, Solid Microneedle Patches, Hollow Microneedle Patches, Coated Microneedle Patches, Hydrogel-Forming Microneedle Patches |
| Application | Cosmetics, Drug Delivery, Vaccination and Others | |
| End-User | Hospitals and Clinics, Cosmetic Clinics, Homecare Settings, Others | |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa | |
Why Purchase the Report?
- Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
- Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
- Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
- Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
- Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
- Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
- Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
- Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
- Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
- Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
- Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
- Post-market Surveillance: Uses post-market data to enhance product safety and access.
- Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.
The global microneedle patches market report delivers a detailed analysis with 62 key tables, more than 56 visually impactful figures and 169 pages of expert insights, providing a complete view of the market landscape.
Target Audience 2025
- Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
- Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
- Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
- Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
- Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
- Supply Chain: Distribution and Supply Chain Managers.
- Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
- Academic & Research: Academic Institutions.
